Spotlight: Eric Chehab, Ph.D., Ferolyn Fellow

Seemingly intractable issues often have simple, elegant solutions when approached with creativity. That’s what Eric Chehab, Ph.D., has found in his work designing products that solve problems in neonatal care.

As the newest addition to the Ferolyn Fellowship class, he has already attained notable accomplishments in his young career, including co-founding and spearheading Novonate.

Q&A with Mike Mussallem, Chairman and CEO of Edwards Lifesciences

Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.

Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,

Raydiant Oximetry Raises Series A Funding; Graduates from Fogarty Institute

Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital. It follows on the heels of a recent string of funding rounds, grants and an exit by fellow Fogarty companies Enspectra

EchoPixel Launches Intraoperative Device; Targets Structural Heart Disease

EchoPixel’s revolutionary technology is rapidly gaining adoption, having already been implemented by over 20 percent of the congenital heart defect programs in the U.S. and used extensively in complex, life-saving surgeries. It has played an essential role in several high-profile cases and has proven successful in both open surgery and interventional procedures.

Spotlight: Maria Artunduaga, MD, MPH, MTM, Ferolyn Fellow

When her beloved grandmother died from chronic obstructive pulmonary disease (COPD), a progressive lung condition that obstructs breathing, Maria Artunduaga, MD, MPH, MTM, realized it was an area that needed attention. That incident became a turning point in her training, leading her to the next phase of what has already been a highly accomplished career.

Q&A with Deborah Kilpatrick, Ph.D., CEO of Evidation Health; Ferolyn Fellowship Advisory Board Member

If you want a snapshot of Deborah (Deb) Kilpatrick’s storied career, you need look no further than the numerous accolades she has amassed. As just a sampling, she has been named on lists such as MM&M’s Top 40 Healthcare Transformers, FierceMedicalDevices’ Top Women in Medical Devices, Business Insider’s Most Powerful Women Engineers,

iDentical Gives Patients and Dentists Something To Smile About With Drill-Free Dental Implants That are Lower Cost and More Accessible

Thanks to improved tooth-brushing habits, regular dental care and ubiquitous fluoridation, most Americans have benefited from better tooth health. And yet, many still lose their teeth, whether due to injury, decay or periodontal disease. In fact, studies find that approximately 178 million people in the United States are missing at least one tooth, and a surprising 40 million are missing all their teeth.

Chronus Health, FII’s Newest Company, Poised to Revolutionize $80 Billion U.S. Clinical Laboratory Testing Market

Imagine going to the doctor’s office for your annual check-up. The nurse starts going through the usual tests, such as measuring your blood pressure, heart rate and temperature and completing the blood draw from your arm.

Then the nurse immediately starts testing your blood with a hand-held device, explaining that instead of waiting for the sample to return from the lab,

START TYPING AND PRESS ENTER TO SEARCH